Importance of the Multidrug and Toxin Extrusion MATE/SLC47A Family to Pharmacokinetics, Pharmacodynamics/toxicodynamics and Pharmacogenomics

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2011 Apr 5

PMID 21457222

Citations 62

Authors

Atsushi Yonezawa

Ken-Ichi Inui

Affiliations

Soon will be listed here.

Abstract

The renal organic cation transport system mediates the tubular secretion of cationic compounds including drugs, toxins and endogenous metabolites into urine. It consists of a membrane potential-dependent organic cation transporter at the basolateral membrane and an H(+) /organic cation antiporter at the brush-border membrane. In 2005, human multidrug and toxin extrusion MATE1/SLC47A1 was identified as a mammalian homologue of bacterial NorM. Thereafter, human MATE2-K/SLC47A2 and rodent MATE were found. Functional characterization revealed that MATE1 and MATE2-K were H(+) /organic cation antiporter, mediating the renal tubular secretion of cationic drugs in cooperation with the basolateral organic cation transporter OCT2. Recently, substrate specificity, transcription mechanisms, structure, polymorphisms, in vivo contributions and clinical outcomes on MATE have been investigated intensively. In this review, we summarize recent findings on MATE1/SLC47A1 and MATE2-K/SLC47A2 and discuss the importance of these transporters to the pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics of cationic drugs.

Citing Articles

Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.

Wagner C Nephrol Dial Transplant. 2025; 40(Supplement_1):i18-i28.

PMID: 39907544 PMC: 11795650. DOI: 10.1093/ndt/gfae211.

Modulation of Multispecific Transporters by Extract and Its Major Phytoconstituents.

Szilvasy N, Lajer P, Horvath A, Veres K, Hohmann J, Schelz Z Pharmaceutics. 2024; 16(11).

PMID: 39598486 PMC: 11597817. DOI: 10.3390/pharmaceutics16111363.

Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects.

Jony M, Ahn S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204140 PMC: 11360778. DOI: 10.3390/ph17081035.

Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters.

Rox K, Kuhne A, Herrmann J, Jansen R, Huttel S, Bernecker S ACS Pharmacol Transl Sci. 2024; 7(7):2093-2109.

PMID: 39022358 PMC: 11249637. DOI: 10.1021/acsptsci.4c00183.

Characterization of Organic Anion and Cation Transport in Three Human Renal Proximal Tubular Epithelial Models.

Meijer T, da Costa Pereira D, Klatt O, Buitenhuis J, Jennings P, Wilmes A Cells. 2024; 13(12.

PMID: 38920639 PMC: 11202273. DOI: 10.3390/cells13121008.

References

Becker M, Visser L, van Schaik R, Hofman A, Uitterlinden A, Stricker B . Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes. 2009; 58(3):745-9. PMC: 2646075. DOI: 10.2337/db08-1028. View

Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K . Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006; 319(2):879-86. DOI: 10.1124/jpet.106.110346. View

Terada T, Inui K . Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem Pharmacol. 2008; 75(9):1689-96. DOI: 10.1016/j.bcp.2007.12.008. View

Matsuzaki T, Morisaki T, Sugimoto W, Yokoo K, Sato D, Nonoguchi H . Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. Drug Metab Dispos. 2008; 36(4):649-54. DOI: 10.1124/dmd.107.019869. View

Chen Y, Zhang S, Sorani M, Giacomini K . Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther. 2007; 322(2):695-700. DOI: 10.1124/jpet.107.123554. View

Zu Schwabedissen H, Verstuyft C, Kroemer H, Becquemont L, Kim R . Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms. Am J Physiol Renal Physiol. 2010; 298(4):F997-F1005. DOI: 10.1152/ajprenal.00431.2009. View

Nakagawa S, Masuda S, Nishihara K, Inui K . mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats. Biochem Pharmacol. 2009; 79(1):67-76. DOI: 10.1016/j.bcp.2009.07.015. View

Inui K, Masuda S, Saito H . Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 2000; 58(3):944-58. DOI: 10.1046/j.1523-1755.2000.00251.x. View

Zhang X, Wright S . MATE1 has an external COOH terminus, consistent with a 13-helix topology. Am J Physiol Renal Physiol. 2009; 297(2):F263-71. PMC: 2724245. DOI: 10.1152/ajprenal.00123.2009. View

10.

Zhang X, Cherrington N, Wright S . Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. Am J Physiol Renal Physiol. 2007; 293(1):F360-70. DOI: 10.1152/ajprenal.00102.2007. View

11.

Shu Y, Sheardown S, Brown C, Owen R, Zhang S, Castro R . Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest. 2007; 117(5):1422-31. PMC: 1857259. DOI: 10.1172/JCI30558. View

12.

He X, Szewczyk P, Karyakin A, Evin M, Hong W, Zhang Q . Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature. 2010; 467(7318):991-4. PMC: 3152480. DOI: 10.1038/nature09408. View

13.

Takano M, Inui K, Okano T, Saito H, Hori R . Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles. Biochim Biophys Acta. 1984; 773(1):113-24. DOI: 10.1016/0005-2736(84)90556-x. View

14.

Nakamura T, Yonezawa A, Hashimoto S, Katsura T, Inui K . Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity. Biochem Pharmacol. 2010; 80(11):1762-7. DOI: 10.1016/j.bcp.2010.08.019. View

15.

Jonker J, Wagenaar E, Van Eijl S, Schinkel A . Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol. 2003; 23(21):7902-8. PMC: 207626. DOI: 10.1128/MCB.23.21.7902-7908.2003. View

16.

Asaka J, Terada T, Tsuda M, Katsura T, Inui K . Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE). Mol Pharmacol. 2007; 71(6):1487-93. DOI: 10.1124/mol.106.032938. View

17.

Sato T, Masuda S, Yonezawa A, Tanihara Y, Katsura T, Inui K . Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1. Biochem Pharmacol. 2008; 76(7):894-903. DOI: 10.1016/j.bcp.2008.07.005. View

18.

Hori R, Maegawa H, Okano T, Takano M, Inui K . Effect of sulfhydryl reagents on tetraethylammonium transport in rat renal brush border membranes. J Pharmacol Exp Ther. 1987; 241(3):1010-6. View

19.

Chen Y, Teranishi K, Li S, Yee S, Hesselson S, Stryke D . Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J. 2009; 9(2):127-36. PMC: 2949062. DOI: 10.1038/tpj.2008.19. View

20.

Christian Jr C, MEREDITH C, Speeg Jr K . Cimetidine inhibits renal procainamide clearance. Clin Pharmacol Ther. 1984; 36(2):221-7. DOI: 10.1038/clpt.1984.166. View